Ask AI
Julie M. Vose

Julie M. Vose, MD, MBA

Payne Distinguished Chair of Oncology
Professor of Medicine
University of Nebraska Medical Center
Omaha, Nebraska

Explore Activities by Julie M. Vose

Title
Format
Credit Type
Credits
Interactive Treatment Decision Tool for MCL: A US Perspective

Content Format:

Tool

Credit Type:

--

Credits:

--
Increasing Complexity in MCL Treatment Decisions and the Value of Interactive Tools

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Application of Evolving Evidence in Mantle Cell Lymphoma: Therapeutic Strategies Using BTK Inhibitors

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

1.75
Optimizing Frontline Treatment for MCL: Considerations for BTK Inhibitors in Younger, Fit Patients

Content Format:

Slideset

Credit Type:

--

Credits:

--
Novel Targeted Therapies in Relapsed/Refractory Follicular Lymphoma: Experts Answer Frequently Asked Questions

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Expert Guide: What’s New and Next for Novel Targeted Therapies in Relapsed/Refractory Follicular Lymphoma

Content Format:

Video

Credit Type:

AMA

Credits:

2.00
CAR T-Cell Therapy in the Management of Relapsed/Refractory Follicular Lymphoma

Content Format:

Slideset

Credit Type:

--

Credits:

--
FAQs: Current and Emerging Roles of BTK Inhibitors in MCL

Content Format:

Clinical Thought

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Mantle Cell Lymphoma: Novel Therapeutic Strategies Using the New Generation of BTK Inhibitors

Content Format:

Slideset

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Mantle Cell Lymphoma: Novel Therapeutic Strategies Using the New Generation of BTK Inhibitors

Content Format:

Video

Credit Type:

ABIM MOC | ACPE | AMA | ANCC

Credits:

1.00
Experts Answer Questions on Integrating CAR T-Cell Therapy Into the Management of DLBCL, FL, MCL, and CLL/SLL to Improve Outcomes

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Integrating CAR T-Cell Therapy Into the Management of DLBCL, FL, MCL, and CLL/SLL to Improve Outcomes

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
Integrating CAR T-Cell Therapy Into the Management of DLBCL, FL, MCL, and CLL/SLL to Improve Outcomes

Content Format:

Slideset

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: MCL Expert Treatment Guidance

Content Format:

Tool

Credit Type:

--

Credits:

--
FAQs: Optimizing the Care of Patients With Relapsed/Refractory MCL

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Experts Discuss Advances in the Use of BTK Inhibitors for the Treatment of Relapsed/Refractory MCL

Content Format:

Video

Credit Type:

AMA

Credits:

2.00
Experts Discuss Advances in the Use of BTK Inhibitors for the Treatment of Relapsed/Refractory MCL

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Noncovalent BTK Inhibitors in Mantle Cell Lymphoma: What You Should Know

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--